 FT. MYERS, FL ACCESSWIRE June 3, 2022 NeoGenomics, Inc. NASDAQ:NEO, a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced that senior management will be participating in multiple upcoming institutional investor conferences. Management will participate in investor meetings and a presentation at the William Blair 42nd Annual Growth Stock Conference in Chicago, on Wednesday, June 8, 2022. 